Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma

NCT06327269 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT06327269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06327269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
Lead sponsor
Chang Gung Memorial Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2021
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk of recurrence